Transurethral needle ablation (TUNA) is used to treat an
enlarged prostate gland (benign prostatic hyperplasia, or BPH)
with a needle-shaped device that delivers heat to very precise areas of the
prostate. The device is inserted up the
urethra inside a tube (catheter) that protects other
tissues from being burned. The heat destroys specific areas that are blocking
the flow of urine out of the bladder. This relieves BPH symptoms. The procedure
does not require an overnight stay in the hospital.
The Benign Prostate Hyperplasia (BPH) Symptom Score Index can help your doctor understand how severe enlarged prostate symptoms are.
If your total score is less than seven, your symptoms are considered mild. Higher scores indicate more severe symptoms. Your doctor can discuss your scores with you -- and what they indicate about your need for treatment.
Use the following point scale to answer each of the questions. Total the score from all the questions.
0 = Not at all
3 = About...
has minimal complications. The two most common are an inability to urinate
(urinary retention) in the first 24 hours after surgery and pain while
urinating. Sexual ability is generally not affected.2
The main advantages of this treatment
It can be done without an overnight stay in the
It has a short recovery time, although the symptoms may
take longer to improve.
It has minimal side effects.
The main disadvantages of this treatment are:
You are more likely to need another surgery for BPH later.3
It may not work well for men who have large
Reports have warned that in a small number of cases TUNA has caused serious injuries and complications,
including damage to the penis and urethra. Injuries have required urostomies, partial amputation of the penis, and
other procedures. In December 2000, the U.S. Food and Drug Administration (FDA) issued a warning about these
In this article
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Medical Reference from Healthwise
March 05, 2012
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this